BioNTech SE annual depreciation and amortization
2017
2018
2019
2020
2021
2022
2023
2024
2025
BioNTech SE Depreciation & Amortization Growth & History (BNTX)
BioNTech SE's depreciation and amortization was €382.8M for fiscal 2025.
View full BioNTech SE company overviewBioNTech SE annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €382.8M | €84.8M | +28.46% |
| 2024 | 2024-12-31 | €298.0M | €114.6M | +62.49% |
| 2023 | 2023-12-31 | €183.4M | €60.1M | +48.74% |
| 2022 | 2022-12-31 | €123.3M | €48.1M | +63.96% |
| 2021 | 2021-12-31 | €75.2M | €36.5M | +94.32% |
| 2020 | 2020-12-31 | €38.7M | €4.8M | +14.16% |
| 2019 | 2019-12-31 | €33.9M | €11.9M | +54.20% |
| 2018 | 2018-12-31 | €22.0M | €11.5M | +108.79% |
| 2017 | 2017-12-31 | €10.5M | — | — |
BioNTech SE quarterly depreciation and amortization
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €266.1M | €215.1M | +421.76% |
| Q1 2026 | 2026-03-31 | €121.3M | — | — |
| Q4 2025 | 2025-12-31 | €164.8M | — | — |
| Q3 2025 | 2025-09-30 | €124.2M | — | — |
| Q2 2025 | 2025-06-30 | €51.0M | — | — |
BioNTech SE depreciation and amortization trends
Over the last five fiscal years, BioNTech SE's depreciation and amortization increased from €38.7M to €382.8M, a change of €344.1M. The latest reported quarter, Q2 2026, shows €266.1M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioNTech SE source filings ↗